Olopatadine Hydrochloride
- Product NDC
- 0093-7684
- 11-digit product format
- 000937684
- Labeler code
- 0093
- Product ID
- 0093-7684_a8b263c7-a7ff-4ae5-a218-a87544b122fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Olopatadine Hydrochloride
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA090848
- Marketing category
- ANDA
- Marketing start
- 2018-05-04
- Marketing end
- 2022-03-31
- Substance
- OLOPATADINE HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-7684-32 | 00093768432 | 1 BOTTLE, DROPPER in 1 CARTON (0093-7684-32) > 2.5 mL in 1 BOTTLE, DROPPER | 2018-05-04 | 2022-03-31 | No | No | Current |